Your browser doesn't support javascript.
Combinatorial analysis reveals highly coordinated early-stage immune reactions that predict later antiviral immunity in mild COVID-19 patients.
Capelle, Christophe M; Ciré, Séverine; Domingues, Olivia; Ernens, Isabelle; Hedin, Fanny; Fischer, Aurélie; Snoeck, Chantal J; Ammerlaan, Wim; Konstantinou, Maria; Grzyb, Kamil; Skupin, Alexander; Carty, Cara L; Hilger, Christiane; Gilson, Georges; Celebic, Aljosa; Wilmes, Paul; Del Sol, Antonio; Kaplan, Ian M; Betsou, Fay; Abdelrahman, Tamir; Cosma, Antonio; Vaillant, Michel; Fagherazzi, Guy; Ollert, Markus; Hefeng, Feng Q.
  • Capelle CM; Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg.
  • Ciré S; Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg.
  • Domingues O; Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg.
  • Ernens I; Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.
  • Hedin F; National Cytometry Platform, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
  • Fischer A; Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.
  • Snoeck CJ; Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg.
  • Ammerlaan W; Integrated BioBank of Luxembourg (IBBL), Dudelange, Luxembourg.
  • Konstantinou M; National Cytometry Platform, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
  • Grzyb K; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg.
  • Skupin A; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg; Department of Neuroscience, University California San Diego, La Jolla, CA, USA.
  • Carty CL; Adaptive Biotechnologies, Seattle, WA, USA.
  • Hilger C; Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg.
  • Gilson G; Centre Hospitalier de Luxembourg (CHL), Luxembourg, Luxembourg.
  • Celebic A; Translational Medicine Operations Hub, Competence Centre for Methodology and Statistics, Luxembourg Institute of Health, Strassen, Luxembourg.
  • Wilmes P; Faculty of Science, Technology and Medicine, University of Luxembourg, Esch-sur-Alzette, Luxembourg; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg.
  • Del Sol A; Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Belvaux, Luxembourg; CIC bioGUNE, Bizkaia Technology Park, Derio, Spain; IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.
  • Kaplan IM; Adaptive Biotechnologies, Seattle, WA, USA.
  • Betsou F; Integrated BioBank of Luxembourg (IBBL), Dudelange, Luxembourg; Laboratoire National de Santé (LNS), Dudelange, Luxembourg.
  • Abdelrahman T; Laboratoire National de Santé (LNS), Dudelange, Luxembourg.
  • Cosma A; National Cytometry Platform, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.
  • Vaillant M; Translational Medicine Operations Hub, Competence Centre for Methodology and Statistics, Luxembourg Institute of Health, Strassen, Luxembourg.
  • Fagherazzi G; Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.
  • Ollert M; Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg; Department of Dermatology and Allergy Center, Odense Research Center for Anaphylaxis (ORCA), University of Southern Denmark, Odense, Denmark. Electronic address: markus.ollert@lih.lu.
  • Hefeng FQ; Department of Infection and Immunity, Luxembourg Institute of Health (LIH), Esch-sur-Alzette, Luxembourg. Electronic address: feng.he@lih.lu.
Cell Rep Med ; 3(4): 100600, 2022 04 19.
Article in English | MEDLINE | ID: covidwho-2004609
ABSTRACT
While immunopathology has been widely studied in patients with severe COVID-19, immune responses in non-hospitalized patients have remained largely elusive. We systematically analyze 484 peripheral cellular or soluble immune features in a longitudinal cohort of 63 mild and 15 hospitalized patients versus 14 asymptomatic and 26 household controls. We observe a transient increase of IP10/CXCL10 and interferon-ß levels, coordinated responses of dominant SARS-CoV-2-specific CD4 and fewer CD8 T cells, and various antigen-presenting and antibody-secreting cells in mild patients within 3 days of PCR diagnosis. The frequency of key innate immune cells and their functional marker expression are impaired in hospitalized patients at day 1 of inclusion. T cell and dendritic cell responses at day 1 are highly predictive for SARS-CoV-2-specific antibody responses after 3 weeks in mild but not hospitalized patients. Our systematic analysis reveals a combinatorial picture and trajectory of various arms of the highly coordinated early-stage immune responses in mild COVID-19 patients.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Cell Rep Med Year: 2022 Document Type: Article Affiliation country: J.xcrm.2022.100600

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / COVID-19 Type of study: Cohort study / Observational study / Prognostic study / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Cell Rep Med Year: 2022 Document Type: Article Affiliation country: J.xcrm.2022.100600